CENTRAXX INC
10QSB/A, 2000-01-05
BLANK CHECKS
Previous: IDEX SERIES FUND, 497, 2000-01-05
Next: SENSAR CORP /NV/, 8-K, 2000-01-05










































                         UNITED STATES
               SECURITIES AND EXCHANGE COMMISSION
                    Washington, D.C.  20549

                          FORM 10-QSB-A1

[x]  QUARTERLY REPORT UNDER SECTION 13 OR 15 (d) OF THE SECURITIES EXCHANGE
     ACT OF 1934

     For the quarterly period ended: SEPTEMBER 30, 1999

[ ]  TRANSITION REPORT UNDER SECTION 13 OR 15 (d) OF THE SECURITIES EXCHANGE
     ACT OF 1934

     For the transition period from   ------    to  ---------------

     Commission File Number   33-3358-NY

                          CENTRAXX, INC.
                   -------------------------
         (Name of small business issuer in its charter)

              Nevada                            88-0224219
      ------------------------               ------------------
(State or other Jurisdiction of               (I.R.S. Employer
 incorporation or organization)              Identification No.)

              2700 Argentia Road, Suite #1000
            Mississauga, Ontario Canada L5N 5V4
    -----------------------------------------------------------
    (Address of principal executive offices)          (Zip Code)

             Issuer's telephone number (905) 826-9988

Check whether the issuer (1) filed all reports required to be filed by Section
13 or 15 (d) of the Exchange Act during the past 12 months (or for such
shorter period that the Company was required to file such reports), and (2)
has been subject to such filing requirements for the past 90 days.

    (1)   Yes [x] No [ ]              (2)   Yes [x]  No [ ]

               (ISSUERS INVOLVED IN BANKRUPTCY  PROCEEDINGS
                        DURING THE PAST FIVE YEARS)

Check whether the issuer has filed all documents and reports required to be
filed by Section 12, 13 or 15(d) of the Exchange Act after the distribution of
securities under a plan confirmed by a court.  Yes     No
                                                   ---    ---

                  (APPLICABLE ONLY TO CORPORATE ISSUERS)

     State the number of outstanding shares of each of the Issuer's classes of
common equity, as of the latest practicable date:

                           September 30, 1999
                        common - 17,907,081 shares

Transitional Small Business Disclosure Format (Check One) : Yes [x] No [ ]


Item 1.   Financial Statements

     The consolidated financial statements of the Company required to be filed
with this Form 10-QSB Quarterly Report were prepared by management and
commence on the following page, together with related Notes.  In the opinion
of management, these Consolidated Financial Statements faily present the
financial condition of the Company.

<TABLE>
                          CENTRAXX, INC
                          BALANCE SHEET
                     AS AT SEPTEMBER 30, 1999
<CAPTION>

ASSETS
                                      30-Sep-99    31-Dec-98    30-Sep-98
                                     (unaudited)   (audited)   (unaudited)
<S>                                   <C>          <C>          <C>
Current

Cash                                          0         142          24,606
Prepaid expenses                          4,949      20,109           5,455

                                          4,949      20,251          30,061

Capital assets (note 3)                 224,028     263,362         271,753
Patent costs (note 1)                    16,734      15,401          15,401

                                        240,762     278,764         287,154

                                        245,711     299,014         317,215


LIABILITIES

Current

Bank overdraft                              326           0               0
Accounts payable and accrued costs      721,045     325,226         241,162

                                        721,371     325,226         241,162


Long Term

Convertible Debenture (note 5)          251,482           0               0

                                        972,853     325,226         241,162

SHAREHOLDERS' EQUITY

Paid up Share Capital (note 6)        2,284,889   1,629,063       1,286,542
Deficit                              -3,012,032  -1,655,275      -1,210,490

                                       -727,143     -26,212          76,052

                                        245,711     299,014         317,215

</TABLE>

<TABLE>

                          CENTRAXX, INC
               STATEMENT OF OPERATIONS AND DEFICIT
            FOR THE 9 MONTHS ENDED SEPTEMBER 30, 1999
<CAPTION>
                                                               Cumulative
                                                                 from
                 9 months   9 months    3 month    3 months     inception to
                 30-Sep-99   30-Sep-98   30-Sep-99  30-Sep-98  30-Sep-99
               (unaudited)  (unaudited) (unaudited)(unaudited) (unaudited)
<S>             <C>          <C>         <C>         <C>        <C>

Revenue              0             0          0          0            0

Expenses

Marketing          88,488        80,794     21,160     80,794      204,971
Management fees   135,527        90,396     45,563     30,132      307,058
Professional
 fees              39,471        37,673      7,744     29,821      156,505
Rent               26,750        28,826      9,373      8,437       79,311
Salaries and
 other adminis-
 tration          420,759        84,051    167,115      3,545      636,152
Loss on write-
 down of invest-
 ment in subsi-
 diary                  0        53,800          0     17,306       53,800
Total general and
 administrative
 costs            710,994       375,540    250,954    170,035    1,437,795


Research and
 product develop-
 ment costs       593,959       528,740    205,492    351,511    1,437,390

Loss for the
 period before
 amortization  -1,304,953      -904,280   -456,446   -521,546   -2,875,185

Amortization       51,804        51,026     18,176     17,007      136,847

Loss for the
  period       -1,356,757      -955,305   -474,622   -538,553   -3,012,032

Deficit, at the
 beginning of
 the period    -1,655,275      -255,185 -2,537,410   -671,937             0

Deficit, at the
 end of the
 period        -3,012,032    -1,210,490 -3,012,032 -1,210,490   -3,012,032


Basic loss per
 share
 (note 2d)         ($0.08)       ($0.08)    ($0.03)    ($0.04)

# of weighted
 average
 shares        16,775,408    12,707,333 16,775,408 12,707,333

</TABLE>

<TABLE>

                          CENTRAXX, INC
                      STATEMENT OF CASH FLOW
            FOR THE 9 MONTHS ENDED SEPTEMBER 30, 1999

                             9 months     9 months     3 months    3 months
                             30-Sep-99    30-Sep-98    30-Sep-99   30-Sep-98
                            (unaudited)  (unaudited)  (unaudited) (unaudited)
<S>                          <C>          <C>          <C>         <C>
Operating Activities

Loss for the period           -1,356,757    -955,305     -474,622    -538,553
Add back non cash outlays:
Amortization of
 capital assets                   51,804      51,026       18,176      17,007
Loss on write-down
 of investment in subsidiary           0      53,800            0      17,306

                              -1,304,954    -850,480     -456,446    -504,239

Changes in working
 capital items:
(Increase) Decrease
 in Prepaid Expenses              15,160      -4,768        1,973       3,108
Increase (Decrease)
 in Accounts payable             395,821     194,932      209,466    -176,539

Cash Generated (Used)
 in Operating Activities        -893,973    -660,316     -245,007    -677,670

Financing Activities

Advances to subsidiary                 0     -17,306            0     -17,306
Issuance of Convertible
 Debenture                       251,482           0      251,482           0
Issuance of common shares(net)   655,826     689,338            0     637,502

Cash Generated by
 Financing Activities            907,308     672,031      251,482     620,196

Investing Activities

Capital assets (acquired) sold   -12,471      15,365            0      69,360

Patent costs                      -1,333      -3,774            0           0

Cash (Used) Provided
 by Investing Activities         -13,804      11,591            0      69,360

Increase (Decrease) in Cash
 for the Period                     -469      23,306        6,476      11,886

Cash (Overdraft) at the
 Beginning of the Period             142       1,300       -6,802      12,720

Cash (Overdraft) at the
 End of the Period                  -326      24,606         -326      24,606

</TABLE>

                          CENTRAXX, INC.

                NOTES TO THE FINANCIAL STATEMENTS
            FOR THE 9 MONTHS ENDED SEPTEMBER 30, 1999

Note 1    Organization and Description of Business


The Company, incorporated as SRS Technical Inc. under the laws of the State of
Nevada on January 15, 1986, changed its name to Composite Design Inc.
following its purchase of Composite Design Corporation on May 29, 1997. On May
18, 1999, the Company purchased all of the outstanding shares of Centraxx
Corp. through an exchange of one of its shares for each share of Centraxx
Corp. following which the Company changed its name on May 19, 1999 to
Centraxx, Inc.

Centraxx Corp., incorporated under the laws of the Province of Ontario of
Canada on August 8, 1997, is a wireless data communications company
specializing in providing location technology solutions. The Company is
developing a proprietary radio location two-way land-based system utilizing
single-point tracking ("UNI-POINT(tm) "technology) which can be deployed to
provide effective solutions for numerous safety, security and location
information needs in multiple network and stand-alone applications.

Note 2    Significant Accounting Policies

These financial statements have been prepared in accordance with generally
accepted accounting principles in the United States. Significant accounting
policies are outlined below:

             a)         BASIS OF PRESENTATION

               On May 18, 1999, the Company, formerly Composite Design Inc.,
               purchased all of the outstanding shares of Centraxx Corp.
               through an exchange of one of its shares for each share of
               Centraxx Corp. (the "Transaction").  As a result of the
               Transaction, the shareholders of Centraxx Corp. owned
               approximately 85% of the outstanding shares of the Company
               and, accordingly, the purchase of Centraxx Corp. by the
               Company is accounted for as a reverse takeover transaction
               under generally accepted accounting principles.

               Under the principles of reverse takeover accounting, the
               consolidated financial statements of the Company, the legal
               parent, are presented as a continuation of the financial
               position and results from operations of Centraxx Corp., the
               legal subsidiary. Application of reverse takeover accounting
               results in the following:


               (i)  The consolidated financial statements of the combined
                    entity are issued under the name of the legal parent,
                    Centraxx Inc, but are considered a continuation of the
                    financial statements of the legal subsidiary, Centraxx
                    Corp.;


               (ii)      As Centraxx Corp.  is deemed to be the acquirer for
                         accounting purposes, its assets and liabilities are
                         included in the consolidated financial statements at
                         their historical carrying values;


               (iii)     Any comparative numbers are those of Centraxx Corp.;
                         and;


                (iv)     For purposes of the accounting for the Transaction,
                         control of the net assets and operations of the
                         Company is deemed to have been acquired by Centraxx
                         Corp. effective April 30,1999.  Accordingly, the net
                         asset value of the Company in the amount of -$12,024
                         plus $ 52,000 of transaction costs has been applied
                         to reduce the share capital of the Company
                         immediately prior to the reverse takeover.

          b)   CAPITAL ASSETS

               Capital assets are recorded at the lower of cost less
               accumulated amortization and net recoverable amount.  All
               capital assets are amortized over 5 years on a straight-line
               basis.

          c)   ESTIMATES

               The preparation of financial statements in conformity with
               generally accepted accounting principles requires management
               to make estimates and assumptions that affect the reported
               amounts of assets and liabilities and disclosure of
               contingent assets and liabilities at the date of financial
               statements and reported amounts of expenses during the
               reporting period.  Actual results could differ from those
               estimates.

          d)   BASIC LOSS PER COMMON SHARE

               Basic loss per common share has been calculated based on the
               weighted average number of common stock outstanding during
               the period.

          e)   RESEARCH AND PRODUCT DEVELOPMENT COSTS

               Research and product development costs are expensed as they
               are incurred.

          f)   PATENT COSTS

               Costs incurred for filing for patents are being capitalized
               and no amortization is taken until all steps necessary to
               establish the patent have been taken.

          g)   MONETARY ASSETS

               Monetary assets and liabilities denominated in currencies
               other than the US dollar are translated at the rate of
               exchange in effect at the end of the period. Expense items
               are translated at the rate of exchange in effect on the
               dates they occur. Exchange gains and losses are reflected in
               operations immediately.

          h)   ACCOUNTING FOR LEASES

               A lease that transfers substantially all the benefits and
               risks incident to ownership of property is treated as a
               capital lease, otherwise the lease is accounted for as an
               operating lease.

Note 3     Capital Assets

Capital assets comprise the following:
<TABLE>
<CAPTION>
                             Cost    Accumulated      Net Book      Net Book
                                    Amortization       Value         Value
                                                   September 30,  December 31,
                                                       1999          1998
<S>                         <C>        <C>         <C>            <C>
Research and Development    $310,821   $117,271      $193,550       225,446
General Office                33,150     12,950        20,200        25,049
Other                         17,695     67,417        10,278        12,867

                            $361,666   $197,638      $224,028      $263,362
</TABLE>

Note 4    Commitments

The Company has the following commitments for equipment:


                              Operating Leases
               1999                44,442
               2000                88,883
               2001                73,011
               2002                 8,133
               2003                     0

Note 5     Convertible Debenture

The Company entered into a $2,000,000 funding arrangement on August 10, 1999,
to be advanced in the minimum monthly amounts as follows:

               August 15, 1999          $100,000
               September 15, 1999       $150,000
               October 15, 1999         $200,000
               November 15, 1999        $200,000
               December 15, 1999        $200,000
               January 15, 2000         $200,000
               February 15, 2000        $350,000
               March 31, 2000           $600,000

                                      $2,000,000

Advances are in the form of an 8% debenture on the assets of the Company
together with a guarantee by the Company's subsidiary. The debenture provides
for a deferment of interest for 2 years, thereafter to be paid quarterly, and
a conversion to stock privilege at any time at the rate of $2.00 per share.

As at September 30, 1999, interest of $1,492 has been accrued on advances
received of $250,000.

Note 6      Share Capital

          (a)  AUTHORIZED AND ISSUED SHARE CAPITAL

          Authorized common shares
          At par value of $.001              200,000,000

          Issued 1999                         17,907,081

            (b)   CAPITALIZATION AND STOCK DATA, INCLUDING CAPITAL CHANGES.
<TABLE>
<CAPTION>
                                                                   Deficit
                                                                  Accumulated
                                                  Additional       During the
                                                   Paid Up        Development
                             Shares      Amount    Capital           Stage
<S>                          <C>         <C>       <C>             <C>
At inception,
 January 15, 1986             25,000        25                        -

Common stock issued for
 cash at approximately
 $8.20 per share                                   204,975
Stock order offering costs        -         -      (45,853)           -
Common stock issued for
 purchasing subsidiary
 at approximately $5.77
 per share                    20,000        20     115,395            -
Recision of common stock
 by SEC                       (8,102)       (8)          8            -
Contributed capital
 by shareholder                   -         -       82,024            -
Loss from inception
 January 15, 1986 to
 December 31, 1994                -         -                      (356,586)

Balance December 31, 1994     36,898        37     356,549         (356,586)

Loss for the year ended
 December 31, 1995                -         -           -             -
Balance, December 31, 1995    36,898        37     356,549         (356,586)

Common Stock issued for
 services at $1.00 per share 162,000       162     161,838            -
Contributed capital by
 shareholder                      -         -        2,149            -
Common stock issued for
 services at $0.001
 per share                  870,000        870          -             -
Stock split adjustment          122         -           -             -
Loss for the year ended
 December 31,1996                 -         -           -           (165,019)
Balance, December 31,
 1996                     1,069,020      1,069     520,536          (521,605)

Contributed capital
 by shareholder                   -         -        1,484            -
Loss for the year ended
 December 31, 1997                -         -           -             (2,179)
Balance, December 31,
 1997                     1,069,020      1,069     522,020          (523,784)

Contributed capital
 by shareholder                   -         -        3,173            -
Loss for the year ended
 December 31, 1998                -         -           -            (11,647)
Balance, December 31,
 1998                     1,069,020     1,069      525,193          (535,431)

Contributed capital
 by shareholder                   -         -          796            -
Loss for the three months
 ended March 31, 1999             -         -           -             (3,651)

Balance, March 31, 1999   1,069,020     1,069      525,989          (539,082)

Stock split adjustment    1,603,530     1,604           -             -
Balance, May 18, 1999-
 Composite Design Inc.    2,672,550     2,673       525,989         (539,082)

Purchase of Centraxx
 Corp.                   15,234,415    15,234     1,792,993       (1,655,275)
Stock offering costs                                (52,000)

Cancellation of Deficit
 of Composite Design
 under reverse takeover
 accounting                                                          539,082
Loss for the six months
 ended June 30, 1999                                                (882,135)

Balance, June 30, 1999    17,906,965   17,907     2,266,982       (2,537,410)
Fractional shares
 rounded up                      116
Loss for the 3 months
 ended September 30, 1999                                           (474,622)
Balance, September 30,
 1999                     17,907,081    17,907    2,266,982       (3,012,032)
</TABLE>

     (c)  STOCK OPTION PLAN

          The Company has provided a means for Directors and employees to be
          granted Options to purchase common shares of the Company or to
          receive a cash amount that is equivalent of the opportunity to
          exercise an Option. The Stock Option Plan provides that a maximum
          of 20% of the Company's issued common shares can be granted unless
          approved by the shareholders of the Company. Options may be
          exercised over a period not to exceed 5 years from the date they
          are granted. The price at which each Option can be exercised can
          not be less than the market price of the common share at the time
          the Options are granted. As at September 30, 1999, 1,290,000
          Options of which 612,151 were vested have been granted at an
          exercise price of $0.70 and 90,000 Options of which 4,055 were
          vested have been granted at an exercise price of $2.00. Options
          vest quarterly.

Note 7      Income Taxes

For tax purposes, the Company has loss carry forwards of approximately $2.8
million available to reduce future taxable income in Canada subject to
qualified investment tax credits. If not utilized, these losses will expire in
the year 2004, 2005 and 2006. In addition, amortization for tax purposes in
the approximate amount of $138,000 may be filed with the tax authorities. The
potential future tax benefits which may result from the application of these
loss carry forwards have not been recorded in these financial statements.

Note 8       Risks and Uncertainties

As a development stage company the business of Centraxx Inc., entails risks
and uncertainties that affect its outlook and eventual results of its business
and commercialization plan.  The primary risks relate to meeting its product
development and commercialization milestones which require that the Company's
products exhibit the cost, durability and performance required in a commercial
product.  There is also a risk that market acceptance might take longer to
develop than anticipated.  The Company's business plan recognizes and, to the
extent possible, attempts to manage these risks by pursuing diverse end
markets for UNI-POINT(tm) technology.  Within these markets the Company's
commercialization plan is focused on products that it believes have a
competitive advantage.  Further, the plan for product and market development
is to work closely with potential strategic partners and key customers who
together have the capability and understanding of their specific markets to
develop products that incorporate Centraxx's UNI-POINT(tm) technology to meet
consumer requirements.

Item 2.   Management's Discussion and Analysis or Plan or Operation.

Plan of Operation
- -----------------

MANAGEMENT'S DISCUSSION AND ANALYSIS OR PLAN OF OPERATION

     This is the second report to stockholders following the acquisition on
May 18, 1999, of all of the outstanding and issued shares of Centraxx Corp., a
corporation organized under the laws of the Province of Ontario, Canada. For
accounting purposes, Centraxx Corp., which became a wholly owned subsidiary of
the Company, is deemed to be the acquirer under a reverse takeover
transaction; accordingly, all figures including comparatives are those of the
legal subsidiary.

     Because of the Company's focus on research and development of its
UNI-POINT technology, which technology is still under development, the Company
has not yet generated any revenues.

RESULTS OF OPERATIONS

Three Months Ended September 30, 1999 compared to September 30, 1998.

     The Company generated a gross loss of ($474,622) during the third quarter
compared to the corresponding 1998 third quarter loss of ($538,553).  The
Company's general and administrative costs increased $164,000 primarily as a
result of increased sales, marketing and administrative personnel, hired in
September 1998, together with related infrastructure costs. Marketing
expenditures were lower in the current quarter compared to the previous year
as a result of the initial ramp up of activities, including trade shows, in
1998.

      The Company's research and product development costs during the third
quarter were lower by $147,000 compared to the corresponding prior year period
primarily as a result of a decreased use of materials and related
infrastructure costs.

Amortization incurred was not materially changed between the respective
3-month periods.

Nine Months Ended September 30, 1999 compared to September 30, 1998.

      The current nine months gross loss was ($1,356,757) compared to
($955,305) for the corresponding 1998 period. The Company's general and
administrative costs increased $336,000 primarily as a result of increased
sales, marketing and administrative personnel, hired in September 1998,
together with related infrastructure costs.

      The Company's research and product development costs increased $69,000
during the current nine month period ended September 30, 1999, as compared to
the prior years period. The primary reasons are the increase in manpower
expenditures of $137,000 as the Company hired a significant number of
additional personnel to assist in the development of its technology offset by
a decrease in materials and expenses directly related to the technology
development during this period. The Company's commitment to UNI-POINT (tm)
technology is reflected by its total cumulative investment in research and
product development since inception in the amount of $1,437,000, representing
50% of the Company's operating cash activities.

Amortization incurred was not materially changed between the respective
6-month periods.

LIQUIDITY AND CAPITAL RESOURCES

     During the third quarter, the Company entered into a financing
arrangement with Frankopan & Co. Inc., a corporation subject to significant
influence by one of the Company's directors, to facilitate ongoing monthly
funding to a total amount of $2 million. A schedule of the monthly amounts,
advanced in the form of a convertible 8% debenture, is included in note 5 of
the financial statements. Centraxx Corp has guaranteed the Company's
obligations under this debenture.  Pursuant to the terms of the debenture,
interest is to be deferred for 2 years.  The principal amount of the debenture
and all accrued interest is convertible in whole or in part at any time and
from time to time into shares of the Company's common stock at a conversion
price, subject to adjustment, of $2.00 per share. The Company expects to
utilize the funds received from such financing for the continuation of the
development of its UNI-POINT(tm) technology and for general operating
purposes. To September 30, 1999, the amount of the advances and accrued
interest amounted to $251,482.

     The Company anticipates that it will require further financing to
effectuate its business plan and to continue its operations for the next
twelve months.  During the balance of the current fiscal year, the Company
expects that its operating capital requirements will be $1 million.  The
Company has engaged Ernst and Young Corporate Finance Inc. to assist it with a
private equity placement of up to $10,000,000.  The planned use from such
offering will be for the implementation of the Company's UNI-POINT(tm)
technology in the corporate markets of Southern Ontario, Canada and Southern
California as well as for the Company's operating capital requirements.
Thereafter, the Company expects that it will need to seek additional capital
through one or more public or private offerings of debt or equity.  There can
be no assurance that the Company will be successful in obtaining any such
funds on terms acceptable to it, if at all.

     The Company is in the process of searching for a President who it expects
will be hired in the last quarter of the current fiscal year. In the interim,
overall management of the Company is being provided by Mr. Michael Ivezic, the
Managing Director of Frankopan & Co., Inc.  Significant increases in the
number of employees, primarily in manufacturing and distribution, are
anticipated during  Q2/ 2000 when the Company's products are expected to be
ready for market launch and the Southern Ontario network is expected to be
established.

RISKS AND UNCERTAINTIES

     As of the date of this Quarterly Report, the Company anticipates that its
technology will not be available for sale or distribution for at least the
next two quarters.  There can be no assurance that the Company will be able to
complete the development of its technology as of that time, or at any time, or
that the Company will be able to sell or distribute its UNI-POINT(tm)
technology to generate profitable operations at that time or in the
foreseeable future.  There can be no assurance that the technology will be
successfully released to the market or that the Company will profit therefrom.

Year 2000
- ---------

     The Year 2000 Issue arises because many computerized systems use two
digits rather than four to identify a year. Date-sensitive systems may
recognize the year 2000 as 1900 or some other date, resulting in errors when
information using year 2000 dates is processed. In addition, similar problems
may arise in some systems which use certain dates in 1999 to represent
something other than a date. The effects of the Year 2000 Issue may be
experienced before, on, or after January 1, 2000, and, if not addressed, the
impact on operations and financial reporting may range from minor errors to
significant systems failures which could affect an entity's ability to conduct
normal business operations. It is not possible to be certain that all aspects
of the Year 2000 Issue affecting the entity, including those related to the
efforts of customers, suppliers, or other third parties, will be fully
resolved.

                    PART II.     OTHER INFORMATION

Item 1.   Legal Proceedings.

     None, not applicable.

Item 2.   Changes in Securities.

     None, not applicable.

Item 3.   Defaults Upon Senior Securities.

     None, not applicable.

Item 4.   Submission of Matters to a Vote of Security Holders.

     None, not applicable.

Item 5.   Other Information.

     None, not applicable.

Item 6.   Exhibits and Other Reports on Form 8-K.

     (a)       Exhibits.



     27   Financial Data Schedule

     (b)       Reports on Form 8-K.

      None, not applicable.


                           SIGNATURE

     Pursuant to the requirements of the Securities and Exchange Act of 1934,
the Registrant has duly caused this Report to be signed on its behalf by the
undersigned, thereunto duly authorized.

                                     CENTRAXX, INC.


Date: 1/5/2000                       /s/Tony Monga
     --------------                  -----------------------------
                                     Tony Monga, Director


     Pursuant to the requirements of the Securities and Exchange Act of 1934,
as amended, this Report has been signed below by the following persons on
behalf of the Company and in the capacities and on the dates indicated:

                                     CENTRAXX, INC.


Date: 1/5/2000                       /s/Tony Monga
     --------------                  -----------------------------
                                     Tony Monga, Director

<TABLE> <S> <C>

<ARTICLE> 5

<S>                             <C>
<PERIOD-TYPE>                   9-MOS
<FISCAL-YEAR-END>                          DEC-31-1999
<PERIOD-END>                               SEP-30-1999
<CASH>                                               0
<SECURITIES>                                         0
<RECEIVABLES>                                        0
<ALLOWANCES>                                         0
<INVENTORY>                                          0
<CURRENT-ASSETS>                                  4949
<PP&E>                                           33150
<DEPRECIATION>                                   12950
<TOTAL-ASSETS>                                  245711
<CURRENT-LIABILITIES>                           721371
<BONDS>                                              0
                                0
                                          0
<COMMON>                                       2284889
<OTHER-SE>                                    (3739175)
<TOTAL-LIABILITY-AND-EQUITY>                    245711
<SALES>                                              0
<TOTAL-REVENUES>                                     0
<CGS>                                                0
<TOTAL-COSTS>                                        0
<OTHER-EXPENSES>                                710994
<LOSS-PROVISION>                                     0
<INTEREST-EXPENSE>                                   0
<INCOME-PRETAX>                               (1356757)
<INCOME-TAX>                                         0
<INCOME-CONTINUING>                                  0
<DISCONTINUED>                                       0
<EXTRAORDINARY>                                      0
<CHANGES>                                            0
<NET-INCOME>                                  (1356757)
<EPS-BASIC>                                    (0.08)
<EPS-DILUTED>                                    (0.08)




© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission